from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1868/-

LFCtreatmentdescriptionclass of inhibitor

-0.268

Amikacinug/mL Amikacintranslation

0.135

Cap5-10ug/mL Capreomycintranslation

0.069

Rox10-50 ug/mL Roxithromycintranslation

-0.061

SM2-5 ug/mL Streptomycintranslation

-0.189

Tet5-10 ug/mL Tetracyclinetranslation

-0.733

Rif0.2-5ug/mL Rifampicintranscription

0.061

Rifp0.1-0.5ug/mL Rifapentinetranscription

4.236

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.170

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.507

CPZ10-50 ug/mL Chlorpromazinerespiration

0.374

Clofazimine10-13 ug/mL Clofaziminerespiration

0.020

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.178

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.009

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.334

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.441

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.008

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.456

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.362

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.628

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.224

KCN5-20 ug/mL Potassium cyaniderespiration

0.136

NaN30.2-2 mM Sodium aziderespiration

0.987

Nigericin50 uM Nigericinrespiration

0.320

TRC10-150 ug/mL Triclosanrespiration

1.284

TRZ10-25 ug/mL Thioridazinerespiration

-0.212

Valinomycin0.5-10 uM Valinomycinrespiration

-0.820

ZnSO42 mM ZnSO4respiration

-0.037

menadione6-10 ug/mL Menadionerespiration

0.290

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.191

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.379

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.430

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.661

NRP_1Non-replicating persistence stage 1dosRassociated

-0.346

Amp0.2mg/mL AmpicillincellWall

-0.157

Cephalexin20-100 ug/mL CephalexincellWall

-0.637

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.787

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.459

EMB10-20 ug/mL EthambutolcellWall

-0.547

Eta12-40 ug/mL EthionamidecellWall

-0.979

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.413

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.764

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.115

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.292

BZA0.12 mg/mL BenzamidearomaticAmides

-0.530

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.368

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.291

H2O24 mM hydrogen peroxideDNAdamaging

-0.103

Levo10 ug/mL LevofloxacinDNAdamaging

-0.498

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.922

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.603

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.687

UVUV-irradiationDNAdamaging

1.018

ARP41-4 ug/mL Antitubercular compound ARP4?

0.157

Antimycin12.5-50 ug/mL Antimycin A?

0.565

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.415

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.183

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.238

PA8240.2-2 ug/mL PA-824?

-0.269

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.493

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.080

Verapamil50 uM Verapamil?

0.302

mercaptoethanol2 mM 2-Mercaptoethanol?

0.550

methoxatin10-20 ug/mL Methoxatin?